NDC 43598-866-04 - ELYXYB
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 43598-866
- Requested NDC
- 43598-866-04
- Package NDCs from labels
- 43598-866-04, 43598-866-09
- Manufacturer
- Dr. Reddy’s Laboratories, Inc | Dr. Reddy's Laboratories, Ltd.
- Effective date
- 2020-05-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ELYXYB - Dr. Reddy’s Laboratories, Inc | Dr. Reddy's Laboratories, Ltd. | Dr. Reddy’s Laboratories, Inc | Dr. Reddy's Laboratories, Ltd. | 2020-05-13 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 43598-866-09 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-a616-a426-e053-dadaa90af4c2 | These highlights do not include all the information needed to use ELYXYB safely and effectively. See full prescribing information for ELYXYB. ELYXYB (celecoxib) oral solution Initial U.S. Approval: 1998 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43598-866-04 | ELYXYB | 4.8 mL in 1 BOTTLE, UNIT-DOSE | SOLUTION | 4.8 | 1 | |
| 43598-866-09 | ELYXYB | 9 in 1 CARTON | SOLUTION | 9 | 1 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| celecoxib | CELECOXIB | A-S Medication Solutions | 85bfe02b-bfcb-44ee-81a0-11765c3054a9 | 2023-02-06 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
| celecoxib | CELECOXIB | Proficient Rx LP | 0ad14a4e-2f05-4ce7-93d1-1cb7e4d8f7d0 | 2022-08-01 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
| celecoxib | CELECOXIB | Proficient Rx LP | cbd2d6de-6f0d-4b69-8e27-a1fe08830ba5 | 2022-04-01 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
| Celecoxib | CELECOXIB | Tianjin Tianyao Pharmaceuticals Co., Ltd. | 76f9bcb7-0e94-485f-816d-61d4e1ed24e0 | 2022-02-28 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
| Celecoxib | CELECOXIB | Aphena Pharma Solutions - Tennessee, LLC | d258e065-e9a6-44e2-89c9-6892d771d9d3 | 2021-08-09 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
| CELECOXIB | CELECOXIB | Proficient Rx LP | c91e5933-1798-4096-9f08-fb1200e154e1 | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
| Celecoxib | CELECOXIB | Proficient Rx LP | 6dd743d3-4821-4919-90eb-6d306ca7999f | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
| a864ef99-fd9f-2b3d-2cb1-dd6f44f6af82 | 34454fef-e029-513c-f843-21f5cd3362ab | 2020-05-13 | Boxed warning, Warnings, Adverse reactions | a864ef99-fd9f-2b3d-2cb1-dd6f44f6af82 34454fef-e029-513c-f843-21f5cd3362ab | ||
| Celecoxib 200 mg | CELECOXIB | Proficient Rx LP | feee6a01-63f9-42c3-8bd8-ca713a08b36d | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
| Celecoxib | CELECOXIB | Proficient Rx LP | 7a234c0c-30a7-49f5-92a1-a1fc836ff9ae | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
| Celecoxib | CELECOXIB | Proficient Rx LP | c787b0ab-77ab-4f7e-9fea-be2a0085020a | 2019-10-01 | Boxed warning, Warnings, Adverse reactions | JCX84Q7J1L |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.